MedTrace Logo

Atrial Fibrillation Detection Using Garmin Wearable Technology

NCT03566836 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2019-09-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the feasibility of detecting atrial fibrillation (AF) in patients with AF using a wearable wrist device/smart watch.

Conditions

Interventions

DEVICE

Garmin Smart Watch

Garmin Smart Watch

DEVICE

Garmin Chest Band

Garmin Chest Band

Sponsors & Collaborators

  • Garmin International

    collaborator INDUSTRY

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Yeruva Madhu Reddy, MD · University of Kansas Medical Center

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-19
Primary Completion
2020-01-31
Completion
2020-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03566836 on ClinicalTrials.gov